MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.

Research site, Ancona, Italy

Research site, Bergamo, Italy

Research site, Foggia, Italy

Research site, Meldola, Italy

Research site, Milan, Italy

Research site, Milan, Italy

Research site, Modena, Italy

Research site, Naples, Italy

Research site, Padova, Italy

Research site, Palermo, Italy

Research site, Pisa, Italy

Research site, Pozzuoli, Italy

Research site, Roma, Italy

Research site, Rozzano, Italy

Research site, Torino, Italy

Research site, Verona, Italy